FacebookTweetPin The stock market has been mostly flat this morning, but things have gotten slightly more positive as Amazon (NASDAQ: AMZN) stopped declining. The company caught fire from the Trump ...

Hims & Hers Health, Inc. HIMS shares jumped 23% to $34.99 after the company announced a collaboration with Novo Nordisk to ...

Younger patients benefit from stricter HbA1c goals, whereas elderly care focuses on symptom control. Glycemic targets should gradually adjust with aging to match changing health and life ...

Obesity drug developers Structure Therapeutics (NASDAQ:GPCR) and Metsera (NASDAQ:MTSR) recorded sharp gains alongside Eli Lilly (NYSE:LLY) on Thursday after the Indiana-based pharma giant reported ...

Obesity drug developers Structure Therapeutics (NASDAQ:GPCR) and Metsera (NASDAQ:MTSR) recorded sharp gains alongside Eli Lilly (NYSE:LLY) on Thursday after the Indiana-based pharma giant reported ...

In this article, we are going to take a look at where Metsera, Inc. (NASDAQ:MTSR) stands against other top insider purchases last month. Will there be a recession? How will new tariffs impact the ...

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Signs of potential liver damage in a study participant led the company to abandon danuglipron, a drug it hoped would help it ...